Efficacy and safety of ticagrelor and clopidogrel in East Asian patients with coronary artery disease undergoing percutaneous coronary intervention-Reference-Cited by-同舟云学术

Efficacy and safety of ticagrelor and clopidogrel in East Asian patients with coronary artery disease undergoing percutaneous coronary intervention

Published:2020-10-01 Issue:11 Volume:36 Page:1739-1745
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Li Jianan¹,Qiu Hong¹,Yan Lirong¹,Guo Tingting¹,Wang Yong¹,Li Yang¹,Zheng Jianfeng¹,Tang Yida¹,Xu Bo¹,Qiao Shubin¹,Yang Yuejin¹,Gao Runlin¹

Affiliation:

1. Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2020.1825364

Reference30 articles.

1. 2014 ESC/EACTS Guidelines on myocardial revascularization

2. 2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction

3. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

4. Novel antiplatelet agents in acute coronary syndrome

5. Antiplatelet Agents for the Treatment and Prevention of Coronary Atherothrombosis

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ticagrelor versus Adjusted‐Dose Prasugrel in Acute Coronary Syndrome with Percutaneous Coronary Intervention;Clinical Pharmacology & Therapeutics;2024-02-19

2. The contribution of genotype-guided selection of P2Y12 inhibitor on prognosis in ACS /CCS patients undergoing percutaneous coronary intervention: a retrospective cohort study;European Journal of Clinical Pharmacology;2023-07-14

3. Clinical Outcomes of Individualized Antiplatelet Therapy Based on Platelet Function Test in Patients After Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis;Journal of Cardiovascular Pharmacology;2023-04

4. Efficacy and Safety of Clopidogrel Versus Ticagrelor for Stabilized Patients With Acute Coronary Syndromes After Percutaneous Coronary Intervention: Results From a Real-World Registry in China;Journal of Cardiovascular Pharmacology;2023-02

5. Comparison of ticagrelor and clopidogrel on platelet function and prognosis in unstable angina;European Journal of Clinical Pharmacology;2022-10-17